Global variability of influenza activity and virus subtype circulation from 2011 to 2023
暂无分享,去创建一个
Jie Wu | Yushi Lin | Kailu Fang | Luyan Zheng | Min Zheng | Jing Yang
[1] New recommendations for the composition of influenza vaccines in 2023 for the southern hemisphere. , 2022, Saudi medical journal.
[2] J. Paget,et al. Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines? , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[3] Jie Wu,et al. Changes in Influenza Activity and Circulating Subtypes During the COVID-19 Outbreak in China , 2022, Frontiers in Medicine.
[4] J. Paget,et al. Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020 , 2022, Influenza and other respiratory viruses.
[5] B. Kuehn. Influenza Vaccination Increased During the COVID-19 Pandemic. , 2021, JAMA.
[6] K. Laurie,et al. Influenza lineage extinction during the COVID-19 pandemic? , 2021, Nature Reviews Microbiology.
[7] John K Billington,et al. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use , 2021, Vaccine.
[8] Jiang Li,et al. Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis , 2021, Journal of global health.
[9] Zhongjie Li,et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States , 2021, Nature Communications.
[10] Gregory L. Watson,et al. An evidence review of face masks against COVID-19 , 2021, Proceedings of the National Academy of Sciences.
[11] Reynold Cheng,et al. Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] L. Brammer,et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020 , 2020, American Journal of Transplantation.
[13] Soyeon Ahn,et al. Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] P. Ueda,et al. Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan. , 2020, JAMA.
[15] M. Chen,et al. Passive immune therapy and other immunomodulatory agents for the treatment of severe influenza: Systematic review and meta‐analysis , 2019, Influenza and other respiratory viruses.
[16] S. Madhi,et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. , 2019, The Lancet. Global health.
[17] H. Ye,et al. Structural Insights for Anti-Influenza Vaccine Design , 2019, Computational and structural biotechnology journal.
[18] J. Peiris,et al. Indirect protection from vaccinating children against influenza in households , 2019, Nature Communications.
[19] M. L. Matute,et al. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014 , 2018, BMC Infectious Diseases.
[20] Jan Kyncl,et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.
[21] O. Pybus,et al. Genome-wide evolutionary dynamics of influenza B viruses on a global scale , 2017, PLoS Pathogens.
[22] D. Krewski,et al. Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis. , 2017, Epidemics.
[23] Daniel Krewski,et al. Reviewing the History of Pandemic Influenza: Understanding Patterns of Emergence and Transmission , 2016, Pathogens.
[24] L. Brammer,et al. Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? , 2016, PloS one.
[25] M. L. Matute,et al. Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? , 2016, PloS one.
[26] P. Zucs,et al. Age-specific differences in influenza virus type and subtype distribution in the 2012/2013 season in 12 European countries , 2015, Epidemiology and Infection.
[27] Timothy B. Stockwell,et al. The contrasting phylodynamics of human influenza B viruses , 2015, eLife.
[28] F. Pozo,et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[29] Stephen A. Martin,et al. Exercise and Respiratory Tract Viral Infections , 2009, Exercise and sport sciences reviews.
[30] L. Melcher. Recommendations for influenza and pneumococcal vaccinations in people receiving chemotherapy. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).